A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
An Open-Label and Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of SER-155 in Adults Undergoing Hematopoietic Stem Cell Transplantation to Reduce the Risk of Infection and Graft vs. Host Disease
Epistemonikos ID: 551aa9dfa7ce3d2ca7d51a8698c6e3790196402b
First added on: May 09, 2024